SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women

BackgroundNumerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, but the overall five-year survival rate is still only 15%. Although cigarette smoking is the primary risk factor for lung cancer, only 7% of female lung cancer patients in Taiwan have a history of smoking. Since cancer results from progressive accumulation of genetic aberrations, genomic rearrangements may be early events in carcinogenesis.ResultsIn order to identify biomarkers of early-stage adenocarcinoma, the genome-wide DNA aberrations of 60 pairs of lung adenocarcinoma and adjacent normal lung tissue in non-smoking women were examined using Affymetrix Genome-Wide Human SNP 6.0 arrays. Common copy number variation (CNV) regions were identified by ≥30% of patients with copy number beyond 2 ± 0.5 of copy numbers for each single nucleotide polymorphism (SNP) and at least 100 continuous SNP variant loci. SNPs associated with lung adenocarcinoma were identified by McNemar’s test. Loss of heterozygosity (LOH) SNPs were identified in ≥18% of patients with LOH in the locus. Aberration of SNP rs10248565 at HDAC9 in chromosome 7p21.1 was identified from concurrent analyses of CNVs, SNPs, and LOH.ConclusionThe results elucidate the genetic etiology of lung adenocarcinoma by demonstrating that SNP rs10248565 may be a potential biomarker of cancer susceptibility.

[1]  W. Gerald,et al.  Identification of DOK genes as lung tumor suppressors , 2010, Nature Genetics.

[2]  T. Ekström,et al.  The human histone deacetylase family. , 2001, Experimental cell research.

[3]  P. Wade.  Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. , 2001, Human molecular genetics.

[4]  Xiang-Jiao Yang,et al.  Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication , 2005, Molecular and Cellular Biology.

[5]  K. Luh,et al.  Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. , 1990, Anticancer research.

[6]  Steven S. Foster,et al.  Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair , 2010, Proceedings of the National Academy of Sciences.

[7]  R. Lothe,et al.  Genomic analysis of prostate carcinoma specimens obtained via ultrasound‐guided needle biopsy may be of use in preoperative decision‐making , 2004, Cancer.

[8]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[9]  C. Le Page,et al.  BTF4/BTNA3.2 and GCS as Candidate mRNA Prognostic Markers in Epithelial Ovarian Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[10]  Bradley P. Coe,et al.  Genome structural variation discovery and genotyping , 2011, Nature Reviews Genetics.

[11]  J. Zhao,et al.  X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer , 2012, Radiation oncology.

[12]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[13]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[14]  H. Sasaki,et al.  PIK3CA gene amplification in Japanese non-small cell lung cancer. , 2007, Lung cancer.

[15]  K. Kelly,et al.  The inherited nature of lung cancer: a pilot study. , 2000, Lung cancer.

[16]  William Pao,et al.  EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. , 2008, The Journal of molecular diagnostics : JMD.

[17]  G. Jenkins.  The role of proteases in transforming growth factor-beta activation. , 2008, The international journal of biochemistry & cell biology.

[18]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[19]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[20]  J. Testa,et al.  Chromosomal imbalances in human lung cancer , 2002, Oncogene.

[21]  Keith W. Jones,et al.  Whole genome DNA copy number changes identified by high density oligonucleotide arrays , 2004, Human Genomics.

[22]  K. Luh,et al.  Chronological observation of epidemiological characteristics of lung cancer in Taiwan with etiological consideration--a 30-year consecutive study. , 1984, Japanese journal of clinical oncology.

[23]  J. Testa,et al.  Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. , 1992, Cancer research.

[24]  S. Hansson,et al.  The novel bone alkaline phosphatase B1x isoform in children with kidney disease , 2006, Pediatric Nephrology.

[25]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[27]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[28]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[29]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[30]  Wim Timens,et al.  Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. , 2009, Lung cancer.

[31]  F. Cappuzzo,et al.  Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer , 2009, Oncogene.

[32]  I. Wistuba,et al.  Smoking molecular damage in bronchial epithelium , 2002, Oncogene.

[33]  M. Namdar,et al.  Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents , 2010, Proceedings of the National Academy of Sciences.

[34]  Y. Shu,et al.  Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  John M. Maris,et al.  Identification of ALK as a major familial neuroblastoma predisposition gene , 2008, Nature.

[36]  E. Connolly,et al.  Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma. , 2006, Neurosurgery.

[37]  Adam M. Gustafson,et al.  A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. , 2011, Lung cancer.

[38]  B. Qian,et al.  Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia , 2012, Nature Genetics.

[39]  Chris Sander,et al.  An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors , 2009, Oncogene.

[40]  P. Hartel,et al.  Del(5q) Is Associated With Clinical and Histological Parameters in Small Cell Neuroendocrine Lung Carcinoma , 2008, International journal of surgical pathology.

[41]  Anthony R. Dallosso,et al.  The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour , 2003, Oncogene.

[42]  L. Ger,et al.  [Risk factors of lung cancer]. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.

[43]  Wei-Guo Zhu,et al.  A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. , 2003, Human molecular genetics.

[44]  N. Kim,et al.  Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. , 2008, Human reproduction.

[45]  Chi-Ying F. Huang,et al.  Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. , 2007, Lung cancer.

[46]  F. Alviano,et al.  Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease? , 2009, Experimental hematology.

[47]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[48]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[49]  J. Minna,et al.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.

[50]  Y. Koyanagi,et al.  Human papillomavirus DNA in squamous cell carcinoma of the lung. , 1996, Journal of clinical pathology.